314 related articles for article (PubMed ID: 14501584)
1. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
Chinetti G; Fruchart JC; Staels B
Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
[TBL] [Abstract][Full Text] [Related]
2. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Chinetti-Gbaguidi G; Staels B
Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
[TBL] [Abstract][Full Text] [Related]
3. Roles of peroxisome proliferator-activated receptor gamma in lipid homeostasis and inflammatory responses of macrophages.
Klappacher GW; Glass CK
Curr Opin Lipidol; 2002 Jun; 13(3):305-12. PubMed ID: 12045401
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors--from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease.
Bouhlel MA; Staels B; Chinetti-Gbaguidi G
J Intern Med; 2008 Jan; 263(1):28-42. PubMed ID: 18042221
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.
Sartippour MR; Renier G
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):104-10. PubMed ID: 10634806
[TBL] [Abstract][Full Text] [Related]
6. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.
Torra IP; Chinetti G; Duval C; Fruchart JC; Staels B
Curr Opin Lipidol; 2001 Jun; 12(3):245-54. PubMed ID: 11353326
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages.
Chinetti G; Lestavel S; Fruchart JC; Clavey V; Staels B
Circ Res; 2003 Feb; 92(2):212-7. PubMed ID: 12574149
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
[TBL] [Abstract][Full Text] [Related]
10. PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor.
Haraguchi G; Kobayashi Y; Brown ML; Tanaka A; Isobe M; Gianturco SH; Bradley WA
J Lipid Res; 2003 Jun; 44(6):1224-31. PubMed ID: 12700342
[TBL] [Abstract][Full Text] [Related]
11. The role of PPARs in atherosclerosis.
Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member.
Michalik L; Desvergne B; Wahli W
Curr Opin Lipidol; 2003 Apr; 14(2):129-35. PubMed ID: 12642780
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
Castrillo A; Tontonoz P
Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
Pineda Torra I; Gervois P; Staels B
Curr Opin Lipidol; 1999 Apr; 10(2):151-9. PubMed ID: 10327283
[TBL] [Abstract][Full Text] [Related]
17. Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma.
Fischer B; von Knethen A; Brüne B
J Immunol; 2002 Mar; 168(6):2828-34. PubMed ID: 11884452
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma and atherosclerosis.
Marx N
Curr Hypertens Rep; 2002 Feb; 4(1):71-7. PubMed ID: 11790295
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst.
Von Knethen A; Brüne B
J Immunol; 2002 Sep; 169(5):2619-26. PubMed ID: 12193733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
